Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

rNAPc2 completes phase Ia testing with positive results

Sep. 25, 1997

Lilly presents structurally novel thrombin inhibitors

Sep. 24, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

TP-9201 as adjunct to thrombolysis in stroke

Sep. 22, 1997

Lilly describes lead for orally active thrombin inhibitors

Sep. 19, 1997

Bisulfated peptide may be clinically useful in venous thrombotic disorders

Sep. 17, 1997

Long-term effects of abciximab in PTCA

Sep. 16, 1997

Molecumetics and Teijin begin oral thrombin inhibitor collaboration

Sep. 15, 1997

Pharmacological characterization of BIBU-52

Sep. 15, 1997

LG Chemical licenses thrombin inhibitor to Warner-Lambert

Sep. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...